National surveys to evaluate prescribing practices: Methodological considerations

Aparasu, Rajender R.; Rege, S.

doi:10.1016/j.sapharm.2021.06.020

Cited by 4 publications

(4 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The results were patient-weighted based on survey design. 44 Binary logistic regression models were fitted to evaluate which variables were associated with short-acting opioid prescription. Subsequently, a multivariable binary logistic regression was fitted to assess the adjusted odds ratio (aOR) and 95% confidence interval (CI) for each selected variable.…”

Section: Discussionmentioning

confidence: 99%

“…Third, we recorded the first medication listed for this study; however, this may have underestimated the results as the NAMCS allows for up to 30 medications depending on the survey year 23 . Finally, NAMCS is a nationwide, publicly available, cross‐sectional data set, and thus no identifiers are provided to assess for patient duplication, nor information available for patients who received prescriptions outside of the ambulatory setting 44 . Given that follow‐up data is not available, we are not able to assess whether individual patients received their short‐acting opioid medications and whether they took these medications as prescribed.…”

Section: Discussionmentioning

confidence: 99%

“…Copyright ©2016 SAS Institute Inc. SAS and all other SAS Institute Inc. product or service names are registered trademarks or trademarks of SAS Institute Inc. The results were patient‐weighted based on survey design 44 . Binary logistic regression models were fitted to evaluate which variables were associated with short‐acting opioid prescription.…”

Section: Methodsmentioning

confidence: 99%

“…23 Finally, NAMCS is a nationwide, publicly available, cross-sectional data set, and thus no identifiers are provided to assess for patient duplication, nor information available for patients who received prescriptions outside of the ambulatory setting. 44 Given that follow-up data is not available, we are not able to assess whether individual patients received their short-acting opioid medications and whether they took these medications as prescribed. Overall, we found higher odds of short-acting opioid prescriptions for patients with WC insurance; however, further work is needed to evaluate the ramifications of this finding.…”

Section: Short-acting Opioid Prescriptionmentioning

confidence: 99%

See 3 more Smart Citations

Short‐acting opioid prescriptions and Workers' Compensation using the National Ambulatory Medical Care Survey

Thompson,

Govindarajulu,

Doucette

et al. 2024

American J Industrial Med

View full text Add to dashboard Cite

BackgroundShort‐acting opioids have been utilized for pain management with little known about their use in patients on Workers' Compensation (WC) insurance. Our goal was to investigate this association in the ambulatory care setting.MethodsUsing the National Ambulatory Medical Care Survey, visits from patients aged 18–64 during the years 2010 until 2018 were evaluated (excluding 2017 due to data availability). Demographic and co‐morbidity data from each visit was obtained along with the visit year. The first short‐acting opioid medication prescribed in the database was considered. Survey‐weighted frequencies were evaluated. Logistic regression estimated the crude and adjusted odds ratios (OR) with 95% confidence intervals for the use of short‐acting opioid prescription.ResultsThere were 155,947 included visits with 62.5% for female patients. Most patients were White with 11.7% identifying as Black, and 6% identifying as another race. Over 13% of the sample was of Hispanic descent. WC was the identified insurance type in 1.6% of the sample population. Of these patients, 25.6% were prescribed a short‐acting opioid, compared with 10.1% of those with another identified insurance. On multivariable regression, Black patients had increased odds of being prescribed a short‐acting opioid compared to white patients (OR: 1.22, 95% CI: 1.11–1.34). Those on WC had 1.7‐fold higher odds of being prescribed short‐acting opioids (95% CI: 1.46–2.06).ConclusionCertain patient characteristics, including having WC insurance, increased the odds of a short‐acting opioid prescription. Further work is needed to identify prescribing patterns in specific high‐risk occupational groups, as well as to elicit potential associated health outcomes.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Section: Short-acting Opioid Prescriptionmentioning

confidence: 99%

See 2 more Smart Citations

Short‐acting opioid prescriptions and Workers' Compensation using the National Ambulatory Medical Care Survey

Thompson,

Govindarajulu,

Doucette

et al. 2024

American J Industrial Med

View full text Add to dashboard Cite

show abstract

Opioid Treatment for Adults With and Without Systemic Autoimmune/Inflammatory Rheumatic Diseases: Analysis of 2006–2019 United States National Data

Huang,

Bruera,

Agarwal

et al. 2024

Arthritis Care & Research

View full text Add to dashboard Cite

ObjectivesThis study compared opioid prescribing among ambulatory visits with Systemic Autoimmune/Inflammatory Rheumatic Diseases (SARDs) or without, and assessed factors associated with opioid prescribing in SARDs.MethodsThis cross‐sectional study used the National Ambulatory Medical Care Survey between 2006 and 2019. Adult (≥18) visits with a primary diagnosis of SARDs, including rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, or systemic lupus erythematosus were included in the study. Opioid prescribing was compared between those with vs. without SARDs using multivariable logistic regression (MLR) accounting for the complex survey design and adjusting for predisposing, enabling, and need factors within Andersen's Behavioral Model of Health Services Use. Another MLR examined the predictors associated with opioid prescribing in SARDs.ResultsAnnually, an average of 5.20 (95% CI 3.58‐6.82) million visits were made for SARDs, whereas 780.14 (95% CI 747.56‐812.72) million visits were made for non‐SARDs. The SARDs group was more likely to be prescribed opioids (22.53%) than the non‐SARDs group (9.83%) (aOR 2.65 [95% CI 1.68‐4.18]). Among the SARDs visits, adults aged 50‐64 (aOR 1.95 [95% CI 1.05‐3.65] relative to ages 18‐49) and prescribing of glucocorticoids (aOR 1.75 [95% CI 1.20‐2.54]) were associated with an increased odd of opioid prescribing, whereas private insurance relative to Medicare (aOR 0.50 [95% CI 0.31‐0.82]) was associated with a decreased odds of opioid prescribing.ConclusionsOpioid prescribing in SARDs was higher compared to non‐SARDs. Concerted efforts are needed to determine the appropriateness of opioid prescribing in SARDs.

show abstract

Large administrative datasets

Ference

2024

Big Data in Otolaryngology

View full text Add to dashboard Cite

National surveys to evaluate prescribing practices: Methodological considerations

Cited by 4 publications

References 11 publications

Short‐acting opioid prescriptions and Workers' Compensation using the National Ambulatory Medical Care Survey

Short‐acting opioid prescriptions and Workers' Compensation using the National Ambulatory Medical Care Survey

Opioid Treatment for Adults With and Without Systemic Autoimmune/Inflammatory Rheumatic Diseases: Analysis of 2006–2019 United States National Data

Large administrative datasets

Contact Info

Product

Resources

About